High-Performance Liquid Chromatography Assay for Moxifloxacin in Brain Tissue and Plasma: Validation in a Pharmacokinetic Study in a Murine Model of Cerebral Listeriosis

Moxifloxacin is a broad-spectrum antibacterial 8-methoxy-fluoroquinolone. In order to evaluate the pharmacokinetic properties of moxifloxacin in mouse plasma and brain tissue, we developed a high-performance liquid chromatography (HPLC) method. This study was based on single-drug delivery, intraveno...

Full description

Saved in:
Bibliographic Details
Main Authors: Renaud Respaud, Solene Grayo, Eric Singlas, Sophie Dubouch, Alban Le Monnier, Marie-Catherine Lott
Format: Article
Language:English
Published: Wiley 2012-01-01
Series:Journal of Analytical Methods in Chemistry
Online Access:http://dx.doi.org/10.1155/2012/436349
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832566579928236032
author Renaud Respaud
Solene Grayo
Eric Singlas
Sophie Dubouch
Alban Le Monnier
Marie-Catherine Lott
author_facet Renaud Respaud
Solene Grayo
Eric Singlas
Sophie Dubouch
Alban Le Monnier
Marie-Catherine Lott
author_sort Renaud Respaud
collection DOAJ
description Moxifloxacin is a broad-spectrum antibacterial 8-methoxy-fluoroquinolone. In order to evaluate the pharmacokinetic properties of moxifloxacin in mouse plasma and brain tissue, we developed a high-performance liquid chromatography (HPLC) method. This study was based on single-drug delivery, intravenously dosed in a central listeriosis murine model. The method employed a reversed-phase Lichrospher RP-18 with a precolumn (250×4.6 mm) and a mobile phase composed of a mixture of acetonitrile, methanol, and citric buffer (pH=3.5) with sodium dodecyl sulfate and tetrabutylammonium bromide. Fluorescence detection was performed at an excitation wavelength of 290 nm and an emission wavelength of 550 nm. The relative standard deviation of intra- and inter-day assays was <10%. This validated method led to a short retention time (8.0 min) for moxifloxacin. The standard curves were linear from 5–250 μg/L in plasma and from 0.1–2.5 μg/g of brain tissue. The limits of quantification were 5 μg/L in plasma and 0.1 μg/g in brain tissue. The method enabled the detection of systemic antimicrobial in plasma and in CNS in Listeria-infected mice. Injected moxifloxacin passed through the encephalic barrier within a 30 to 60 min after injection time frame. Moxifloxacin pharmacokinetics are modeled in an infected model compared to control mice.
format Article
id doaj-art-e427d7d8a7504c66be48ca5245bf4f3f
institution Kabale University
issn 2090-8865
2090-8873
language English
publishDate 2012-01-01
publisher Wiley
record_format Article
series Journal of Analytical Methods in Chemistry
spelling doaj-art-e427d7d8a7504c66be48ca5245bf4f3f2025-02-03T01:03:48ZengWileyJournal of Analytical Methods in Chemistry2090-88652090-88732012-01-01201210.1155/2012/436349436349High-Performance Liquid Chromatography Assay for Moxifloxacin in Brain Tissue and Plasma: Validation in a Pharmacokinetic Study in a Murine Model of Cerebral ListeriosisRenaud Respaud0Solene Grayo1Eric Singlas2Sophie Dubouch3Alban Le Monnier4Marie-Catherine Lott5Laboratoire de Suivi Thérapeutique et de Contrôle des Médicaments, Service de Pharmacie, Assistance Publique-Hôpitaux de Paris (AP-HP), Hôpital Necker-Enfants Malades, 75015 Paris, FranceLaboratoire de Listeria, Centre National de Référence des Listeria and World Health Organization Collaborating Centre for Foodborne Listeriosis, Institut Pasteur, 75015 Paris, FranceLaboratoire de Suivi Thérapeutique et de Contrôle des Médicaments, Service de Pharmacie, Assistance Publique-Hôpitaux de Paris (AP-HP), Hôpital Necker-Enfants Malades, 75015 Paris, FranceLaboratoire de Suivi Thérapeutique et de Contrôle des Médicaments, Service de Pharmacie, Assistance Publique-Hôpitaux de Paris (AP-HP), Hôpital Necker-Enfants Malades, 75015 Paris, FranceLaboratoire de Listeria, Centre National de Référence des Listeria and World Health Organization Collaborating Centre for Foodborne Listeriosis, Institut Pasteur, 75015 Paris, FranceLaboratoire de Suivi Thérapeutique et de Contrôle des Médicaments, Service de Pharmacie, Assistance Publique-Hôpitaux de Paris (AP-HP), Hôpital Necker-Enfants Malades, 75015 Paris, FranceMoxifloxacin is a broad-spectrum antibacterial 8-methoxy-fluoroquinolone. In order to evaluate the pharmacokinetic properties of moxifloxacin in mouse plasma and brain tissue, we developed a high-performance liquid chromatography (HPLC) method. This study was based on single-drug delivery, intravenously dosed in a central listeriosis murine model. The method employed a reversed-phase Lichrospher RP-18 with a precolumn (250×4.6 mm) and a mobile phase composed of a mixture of acetonitrile, methanol, and citric buffer (pH=3.5) with sodium dodecyl sulfate and tetrabutylammonium bromide. Fluorescence detection was performed at an excitation wavelength of 290 nm and an emission wavelength of 550 nm. The relative standard deviation of intra- and inter-day assays was <10%. This validated method led to a short retention time (8.0 min) for moxifloxacin. The standard curves were linear from 5–250 μg/L in plasma and from 0.1–2.5 μg/g of brain tissue. The limits of quantification were 5 μg/L in plasma and 0.1 μg/g in brain tissue. The method enabled the detection of systemic antimicrobial in plasma and in CNS in Listeria-infected mice. Injected moxifloxacin passed through the encephalic barrier within a 30 to 60 min after injection time frame. Moxifloxacin pharmacokinetics are modeled in an infected model compared to control mice.http://dx.doi.org/10.1155/2012/436349
spellingShingle Renaud Respaud
Solene Grayo
Eric Singlas
Sophie Dubouch
Alban Le Monnier
Marie-Catherine Lott
High-Performance Liquid Chromatography Assay for Moxifloxacin in Brain Tissue and Plasma: Validation in a Pharmacokinetic Study in a Murine Model of Cerebral Listeriosis
Journal of Analytical Methods in Chemistry
title High-Performance Liquid Chromatography Assay for Moxifloxacin in Brain Tissue and Plasma: Validation in a Pharmacokinetic Study in a Murine Model of Cerebral Listeriosis
title_full High-Performance Liquid Chromatography Assay for Moxifloxacin in Brain Tissue and Plasma: Validation in a Pharmacokinetic Study in a Murine Model of Cerebral Listeriosis
title_fullStr High-Performance Liquid Chromatography Assay for Moxifloxacin in Brain Tissue and Plasma: Validation in a Pharmacokinetic Study in a Murine Model of Cerebral Listeriosis
title_full_unstemmed High-Performance Liquid Chromatography Assay for Moxifloxacin in Brain Tissue and Plasma: Validation in a Pharmacokinetic Study in a Murine Model of Cerebral Listeriosis
title_short High-Performance Liquid Chromatography Assay for Moxifloxacin in Brain Tissue and Plasma: Validation in a Pharmacokinetic Study in a Murine Model of Cerebral Listeriosis
title_sort high performance liquid chromatography assay for moxifloxacin in brain tissue and plasma validation in a pharmacokinetic study in a murine model of cerebral listeriosis
url http://dx.doi.org/10.1155/2012/436349
work_keys_str_mv AT renaudrespaud highperformanceliquidchromatographyassayformoxifloxacininbraintissueandplasmavalidationinapharmacokineticstudyinamurinemodelofcerebrallisteriosis
AT solenegrayo highperformanceliquidchromatographyassayformoxifloxacininbraintissueandplasmavalidationinapharmacokineticstudyinamurinemodelofcerebrallisteriosis
AT ericsinglas highperformanceliquidchromatographyassayformoxifloxacininbraintissueandplasmavalidationinapharmacokineticstudyinamurinemodelofcerebrallisteriosis
AT sophiedubouch highperformanceliquidchromatographyassayformoxifloxacininbraintissueandplasmavalidationinapharmacokineticstudyinamurinemodelofcerebrallisteriosis
AT albanlemonnier highperformanceliquidchromatographyassayformoxifloxacininbraintissueandplasmavalidationinapharmacokineticstudyinamurinemodelofcerebrallisteriosis
AT mariecatherinelott highperformanceliquidchromatographyassayformoxifloxacininbraintissueandplasmavalidationinapharmacokineticstudyinamurinemodelofcerebrallisteriosis